Trump taps RFK Jr. to lead Health and Human Services: If confirmed, the vaccine skeptic’s appointment would hold serious implications for Big Pharma.

Nutritional supplements are popular in the US, but consumers don’t know how ingredients are vetted: The situation presents brand marketers with an opportunity to fill this knowledge gap and connect with shoppers.

Novo asks FDA to ban compounders from making GLP-1 copies: The drugmaker argues Ozempic’s key ingredient is too complex to make safely, even during shortages. With patient access to affordable GLP-1s on the line, the FDA has a difficult decision to make.

Eli Lilly’s GLP-1 medication shortage ends: The host of players who offer compounded versions of the blockbuster drugs don’t have to worry—yet.

FDA warns AbbVie for misleading TV ad ft. Serena Williams: Pharma marketers—particularly those who work with celebrities—ought to pay close attention to the regulator’s assertions.

Apple unveils new Apple Watch feature that detects sleep apnea: The timing of the feature’s unveiling could be the spark Apple needs to reignite its stagnating device business.

Virtual Incision’s plans for a robotic space visit highlight the need to make digital surgery devices much smaller.

We detail the move by retail giants like Walmart into clinical trials and how the data platforms can help maintain equity.

We unpack the potential for cheaper consumer health devices as the FDA makes hearing aids directly available.

Dozens of digital pharmacies have appeared in recent years, jostling for consumers’ attention alongside the digital twins of national retail chains and mass merchandisers. The threat of recession may send more consumers online, looking for lower prescription prices.

The metaverse is expected to be a major disruptor across industries, but it's still early days for the emerging realm. In this report, we look at how different markets are embarking on their own metaverse business models.

As the government continues to wrestle with the coronavirus pandemic, US consumers and news organizations have rediscovered one of the things that made social media so valuable: Democratizing information about a fast-moving global story brings to light important narratives that official sources may miss, ignore or suppress.

Consolidation in the ad industry and straightforward labels could make data-driven advertising easier to comprehend and navigate.